Reubi, J.

tumor somatostatin patient receptor neuroendocrine analogue octreotide neuroendocrine tumors therapy study somatostatin analogues treatment gep-net response carcinoid af finity peptide growth sstr 2 trial tumor size hormone effect cancer month symptom survival internalization disease waser b imaging octreotide lar phase lanreotide combination subtype radionuclide protein review finity binding figure tumor cells sst 2 side effects ef ficacy oncol carcinoid tumors factor syndrome lu-dota hepatology endocrinol reubi somatostatin receptors tissue g protein – somatostatin analogue table gastro carcinoid syndrome pancreatic increase activity som 230 tumours gastroenterology waser cortistatin y-dota secretion reduction tumor growth metastatic survival time result density radiolabeled analog radiotherapy